Resource Centers
Family Medicine Journals
Medscape Community Resources
Related Blogs
POLL
A study published last month in the Archives of Internal Medicine reveals primary care practices sometimes do not inform patients of abnormal lab results or do not keep a record of the patient being informed. About 1 of every 14 abnormal tests was not reported to the patient. How likely or not likely is this to happen in your practice?
- ABILIFY® (aripiprazole)
- ACTONEL® (risedronate sodium tablets)
- Atrial Fibrillation Condition Site
- CRESTOR® (rosuvastatin calcium)
- Carac® (fluorouracil cream 0.5%)
- Ciprodex® (ciprofloxacin 0.3% and dexamethasone 0.1%) Sterile Otic Suspension
- DanActive® and ACTIVIA® Information Center
- Diabetes in America
- GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant]
- GEODON® (ziprasidone HCI)
- Institute for Advances in Point-of-Care Testing
- LEVAQUIN® (levofloxacin) tablets/injection
- LOVAZA® (omega-3-acid ethyl esters)
- NUCYNTA (tapentadol)
- Navigenics® Genetic Risk Assessment Services
- OPTIMAL Forum™
- PREMARIN® (conjugated estrogens tablets, USP)
- ProAir® HFA
- Professional Liability Risk: Facts, Perspectives, and Management Strategies InfoSite
- REBIF® (interferon beta-1a)
- Reclast® (zoledronic acid) injection
- Symbyax® (Olanzapine and Fluoxetine HCl Capsules)
- The Pain Institute
- VESIcare (solifenacin succinate) tablets
- VIGAMOX® solution
- Vyvanse (lisdexamfetamine dimesylate)
Advisory Board
- Bradley Fox, MD
- Valerie Gilchrist, MD
- Alicia Hart, MD
- Desiree Lie, MD, MSEd
- Robert Morrow, MD
- Dennis Salisbury, MD
- Charles Vega, MD
Site Editorial Director